Bluejay Therapeutics Advances in Hepatitis B and D Trials: :

SAN MATEO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a company dedicated to developing innovative treatments for viral and liver...

Related Keywords

, Nancy Shulman , Chief Medical Officer , Bluejay Therapeutics , Keting Chu , Biotechnology , Clinical Trial , Gbv ,